A case study that seeks to investigate the use of Kleresca® FLE treatments to intensify and demask underlying solar lentigines before their targeting with laser therapy.
The paper shows that Kleresca® FLE activates the skin cells to successfully intensify all the SL areas to be targeted by the laser treatment and it is a useful adjunct therapy to prepare the skin before and to rejuvenate it after more invasive therapies. Kleresca® favors a fast recovery and enhances the overall aesthetic results.
Read more about the study in the publication summary.
The Kleresca® platform, utilising fluorescent light energy (FLE), effectively treated both acne conglobata and hidradenitis suppurativa. FLE offers a new treatment approach to recalcitrant inflammatory skin conditions.
The study has the aim to investigate the cellular mechanisms of action of FLE on key skin and immune cells . FLE serves both aesthetic and therapeutic purposes by enhancing collagen production, modulatin cutaneuous inflammation and encouraging angiogenesis.
Patient with a 3 month history of papulopustular eruption result of granulomatous rosacea. A modest improvement was observed with topical systemic treatments. After Kleresca®, there was a significant improvement and no relapse after 6 months it was finalized.
Case study of a 49-year old patient suffering from acne eruption induced by erlotinib treatment. After trying different oral and systemic treatments, the use of Kleresca® Acne Treatment reduce notably the severity of her acne.
A book chapter that explains the clinical experience in the use of Kleresca® (biophotonic therapy) for the treatment of acne patients. The document explains also the efficacy and the patient satisfaction obtained in the clinic.
Three patients were treated with FLE in order to investigate the role in the treatment in targeting inflammation and erythema in rosacea subtypes 1, 2 and 3.
Results proved FLE to be effective with an improvement in the skin texture of the patient.
Explanatory article about the documented benefits of photobiomodulation and fluorescent light energy (FLE), explaining its benefits in acne, skin rejuvenation, and its potential as an alternative therapeutic option to conventional therapies.
A 12-week clinical trial to evaluate the efficacy and safety of the biophotonic system in the treatment of moderate to severe acne vulgaris. The treatment was found to be efficacious and safe, with a sustained clinical response at 12 weeks for the management of moderate to severe facial inflammatory acne.
Extension trial to evaluate the efficacy of the biophotonic system as well as the duration of response. The study confirmed the long duration of effect following treatment as well as excellent patient safety profile.
A patient suffering from papulopustular rosacea receives fluorescent light energy (FLE) treatment. After 5 weeks, the patient showed a marked reduction of the inflammatory reaction and an overall improvement of the large-pored skin type.
The goal of the study is to combine combines two techniques, (laser and biophotonics) to achieve long-term results with moderate to significant improvement in the overall appearance of facial pigmentation, with high patient satisfaction.
Kleresca® utiliza cookies para brindarle la mejor experiencia de navegación posible y para obtener datos agregados y anónimos sobre el uso del sitio web. Pulse «acepto» para dar su consentimiento al uso de las cookies. Si desea información sobre el tipo de cookies que utilizamos, su función y la forma de deshabilitarlas, consulte nuestra política de cookies. También encontrará más información al respecto en nuestra política de privacidad.